Navigation Links
Slone Partners Hosts Precision Medicine Event Led by Michael Pellini, MD with Panelists Troy Cox, Barbara Weber, MD and Roman Yelensky, PhD
Date:6/14/2017

Slone Partners welcomed a panel of premier industry leaders on June 8th to discuss the initiative steered by the executive search firm, “Building Value in Precision Medicine: Can We Overcome the Obstacles?”

Michael Pellini, MD, Chairman of the Board of Directors of Foundation Medicine, led an open discussion with expert panelists Troy Cox, CEO of Foundation Medicine, Barbara Weber, MD, Interim CEO at Tango Therapeutics, and Roman Yelensky, PhD, Chief Technology Officer, Gritstone Oncology.

The panel reviewed the state of the Precision Medicine arena and shared approaches on developing strategic methods and collaborative partnerships to improve patient outcomes. They addressed the extreme challenge of recruiting patients for clinical trials and producing meaningful results with a small group.

“The event was a real success and the topics and opinions shared about the future of diagnostics and personalized medicine were timely and valuable. As a major player and participant in the Precision Medicine space, Slone Partners wants to create opportunities for its client partners and the next generation of industry leaders to find solutions and answers to their concerns,” said Slone Partners Founder, Adam Slone.

The attendees listened to a passionate panel of experts who shared their thoughts on the complex issues and future of personalized medicine and diagnostics. Key topics on the agenda included targeted therapies and the need for increased targeted genetic sequencing in cancer patients. The panelists touched on a tumor-specific approach to finding the right patients for the right treatment rather than a broader disease-specific approach.

“Cancer is a genetic disease and there is no substitute for sequencing every patient’s tumor to find the right treatment and better understand drug resistance and why patients relapse,” stated Tango Therapeutics Interim CEO, Barbara Weber, MD.

“Our goal has been achieved as participants acquired meaningful insights into the Precision Medicine space. Slone Partners will continue to support the advancement of the Precision Medicine industry by hosting more events like this one, bringing together key decision makers and driving the conversation around major issues,” said Slone Partners President, Tara Kochis-Stach.

About Slone Partners

Founded in 2000, Slone Partners is a premier executive search firm that specializes in recruitment for the life sciences, diagnostics, clinical trials, contract research, therapeutics, healthcare information technology, and laboratory testing industries with offices in Boston, Washington, D.C. and San Francisco. Innovative, world-class organizations from across the nation have chosen Slone Partners to fill their key positions.

Read the full story at http://www.prweb.com/releases/2017/06/prweb14424453.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. Slone Partners Pledges its Support as Corporate Benefactor for the 2017 Executive War College
2. Slone Partners Places Chief Executive Officer at La Peer Health Systems
3. Slone Partners Places Chief Executive Officer at Avomeen Analytical Services
4. Slone Partners Designated by Hunt Scanlon Media as one of the “Top 50 Healthcare and Life Science Search Firms”
5. Slone Partners Places President & Chief Commercial Officer at GenePeeks
6. Slone Partners Sponsors the SCOPE Summit for Clinical Ops Executives 2017
7. Slone Partners Fills Head of Sales at Optimal Medicine
8. Executive Search Firm Slone Partners Expands With New San Francisco Office
9. Slone Partners Meets Growing Demand as Industry Focuses on Reimbursement & Regulation
10. Slone Partners CEO & President Speak about Hiring Challenges in Molecular Diagnostics at Executive War College 2013
11. NDA Partners Announces Collaboration Agreement with Qualiminds Corporate Services of Mumbai India
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... (PRWEB) , ... October 11, 2017 , ... Personal eye wash is a basic first ... eye at a time. So which eye do you rinse first if a dangerous substance ... Plum Duo Eye Wash with its unique dual eye piece. , “Whether its ...
(Date:10/11/2017)... ... October 11, 2017 , ... Disappearing forests and increased emissions are ... 5.5 million people each year. Especially those living in larger cities are affected by ... in one of the most pollution-affected countries globally - decided to take action. , ...
(Date:10/10/2017)... ... 10, 2017 , ... For the second time in three ... Mentoring Award. Representatives of the FirstHand program travelled to Washington, D.C. Tuesday, October ... US2020’s mission is to change the trajectory of STEM education in America by ...
(Date:10/10/2017)... ... October 10, 2017 , ... The Pittcon ... awards honoring scientists who have made outstanding contributions to analytical chemistry ... Pittcon 2018, the world’s leading conference and exposition for laboratory science, which will ...
Breaking Biology Technology:
(Date:3/29/2017)... , March 29, 2017  higi, the health IT ... North America , today announced a ... the acquisition of EveryMove. The new investment and acquisition ... of tools to transform population health activities through the ... data. higi collects and secures data today ...
(Date:3/27/2017)... , March 27, 2017  Catholic Health ... and Management Systems Society (HIMSS) Analytics for achieving ... Adoption Model sm . In addition, CHS previously ... U.S. hospitals using an electronic medical record (EMR). ... its high level of EMR usage in an ...
(Date:3/24/2017)... Mar 24, 2017 Research and Markets has ... Market Analysis & Trends - Industry Forecast to 2025" report ... ... at a CAGR of around 15.1% over the next decade to ... report analyzes the market estimates and forecasts for all the given ...
Breaking Biology News(10 mins):